Cancer Control After Robotic Radical Prostatectomy: What Actually Matters
By Dr. Richard Bevan-Thomas
This is the final chapter of the DocRBT Essentials series.
In Parts 1 and 2, we focused on erectile recovery and urinary control — the quality-of-life outcomes that matter deeply after prostate cancer surgery.
Today, we get to the reason we are doing this operation in the first place:
Making sure the cancer is truly gone.
As a surgeon practicing in Arlington and across the DFW Metroplex, my philosophy is simple. Quality of life after surgery matters — but none of it matters unless we first do a good cancer operation.
What Cancer Control Really Means
Cancer control after a robotic radical prostatectomy isn’t a single result or lab value. It’s the outcome of a series of decisions made before, during, and after surgery.
When I talk to patients about cancer control, I focus on four questions:
- Did we remove the cancer completely?
- Was the cancer confined to the prostate, or had it begun to grow outside of it?
- Were the lymph nodes involved?
- Does the PSA drop to undetectable and stay there?
Each of these helps us understand where things stand and what to expect moving forward.
Why Planning Matters So Much in Prostate Cancer Surgery
Precision during surgery is everything.
Robotic prostate surgery allows us to operate with extraordinary clarity and control. Using the da Vinci system, I work with a high-definition, three-dimensional view at up to 10-times magnification, which allows careful identification of tissue planes, nerves, blood vessels, muscle layers, and areas where anatomy is especially tight.
But that precision only helps if we know where to use it.
This is where prostate cancer surgery becomes a bit of a tightrope walk.
At all times, we are balancing two competing priorities:
- Preserving nerves, fascia, and urethral length to protect quality of life
- Minimizing the chance of leaving cancer behind
That balance is not guessed at during surgery. It’s planned carefully before we ever enter the operating room.
Why We Can’t Rely on “Seeing” Cancer During Surgery
Patients often ask whether we can actually see prostate cancer during surgery.
The honest answer is: most of the time, we can’t.
Prostate cancer is usually microscopic. It doesn’t behave like a visible mass that can be reliably identified and avoided. While there are occasional moments during surgery where tissue appearance raises concern — and when that happens, we absolutely adjust our approach — those situations are uncommon.
As a whole, prostate cancer is very difficult to visually distinguish from normal tissue during surgery, even with excellent magnification.
That’s why planning matters so much more than reacting in real time.
Why Frozen Sections Are Rarely Used Today
In the past, surgeons sometimes sent tissue to the pathologist during surgery — called a frozen section — to check for cancer at the margins.
In robotic prostatectomy, frozen sections have proven to be unreliable. The tissue samples are small, altered by freezing, and difficult to interpret accurately in the moment. False reassurance or false concern can lead to poor decisions.
Because of this, frozen sections are rarely used in modern robotic prostate surgery.
Instead, the most reliable approach is:
- Careful preoperative planning
- Thoughtful intraoperative judgment
- And a thorough final pathology report examining the entire prostate
This strategy leads to better cancer control and fewer unnecessary trade-offs.
How We Decide Where to Stay Close — and Where to Go Wider
Before surgery, I carefully study your case and ask several key questions:
- Where is the cancer most likely located within the prostate?
- Are there areas where it may be close to the capsule?
- Are there warning signs that it could be extending beyond the prostate?
Those answers come from combining:
- MRI findings
- Biopsy grade and cancer volume
- PSA level and trends
- The pattern and location of positive biopsy cores
These don’t give certainty — but they give probability. And in surgery, understanding probability is how we stay balanced on that tightrope.
In some areas, the plan may be to work very close to the prostate to preserve nerves and supporting structures. In other areas, the plan may be to intentionally take more tissue to reduce the risk of leaving cancer behind.
That strategy is determined before the operation begins.
Surgical Margins: The “Orange” Rule
One of the first things patients look for on their final pathology report is the word “negative.”
Specifically, negative surgical margins.
I often explain this with a simple analogy.
Think of the prostate like an orange.
My job is to remove the orange without cutting into the fruit, while still staying as close as possible to protect nearby nerves and muscles.
This is another place where we’re walking that same tightrope. Staying too far away risks unnecessary damage to function. Staying too close risks cutting into cancer.
- Negative margins mean cancer cells do not reach the edge of the removed tissue.
- Positive margins mean cancer cells are found at the edge, suggesting microscopic disease may remain.
Achieving negative margins isn’t about being aggressive everywhere — it’s about knowing where to stay close and where to step back.
Extraprostatic Extension (EPE): When Cancer Pushes Outside the Prostate
Sometimes prostate cancer grows right up to the capsule and begins to extend beyond it. This is called extraprostatic extension (EPE).
We look for signs of this using:
- MRI
- Biopsy grade and volume
- PSA trends
If EPE is suspected in a specific area, the plan is to remove a wider margin of tissue there. That shifts the balance of the tightrope toward cancer control in that location.
Finding EPE on final pathology does not mean surgery failed. Often, it confirms that taking additional tissue was the right decision.
What the Final Pathology Report Tells Us
After surgery, every patient receives a final pathology report. Unlike a biopsy, this examines the entire prostate under the microscope.
From this report, we learn:
- The true cancer grade
- Whether the cancer was confined to the prostate
- Whether extraprostatic extension was present
- Whether surgical margins were clear
- Whether lymph nodes were involved (if removed)
For many patients, this report provides clarity and reassurance — turning estimates into definitive answers.
Lymph Nodes: Completing the Cancer Picture
In many cases, we remove pelvic lymph nodes during surgery.
Lymph nodes act as early checkpoints. If prostate cancer spreads, this is often the first place it goes.
- Negative nodes increase confidence that surgery alone is sufficient.
Positive nodes don’t mean surgery failed. They give us valuable information and allow early, targeted treatment when appropriate.
PSA: The Proof After Surgery
Because the prostate is the primary source of PSA, once it is removed, the PSA should fall to undetectable levels.
For many men, seeing that first undetectable PSA is when the emotional weight finally starts to lift.
We continue to monitor PSA closely over time. A stable, undetectable PSA is one of the strongest signs of durable cancer control.
If the Cancer Ever Comes Back: We Still Have Options
If PSA begins to rise after surgery, it does not mean we’re out of options.
In many cases, early, targeted radiation therapy can be very effective at controlling recurrence — especially when caught early.
Because the prostate has already been removed:
- PSA is a very sensitive early warning signal
- Radiation can be delivered more precisely
- Treatment decisions can be made before symptoms develop
Surgery doesn’t close doors. It often creates clarity and keeps future options open.
The Bigger Picture
Robotic radical prostatectomy is not just a technical procedure.
It’s a carefully planned balance — a tightrope — between removing cancer thoroughly and preserving the structures that matter for life afterward. When guided by planning, experience, and close follow-up, surgery offers an excellent chance at long-term cancer control and quality of life.
Take the Next Step in Arlington & DFW
If you’ve been diagnosed with prostate cancer, you don’t have to navigate this alone.
Whether you’re in Arlington, Mansfield, Southlake, or anywhere in the DFW Metroplex, let’s review your MRI, biopsy, PSA, and options together and build a plan that prioritizes both cancer control and life after surgery.
Call: 866-367-8768
Location: Urology Partners of North Texas | Arlington, TX
Book Online: Schedule Your Consultation
Watch: Cancer Control & Robotic Surgery on the DocRBT YouTube Channel
